Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
A 2019 trial report from NEJM offered a comparative analysis of levetiracetam, fosphenytoin, and valproate in managing benzodiazepine-resistant convulsive status epilepticus, providing essential insights into their efficacy and safety, aiding clinicians in informed decision-making.
Neurology April 2nd 2024
This study underscores the complexity of prescribing antiseizure medications during pregnancy, revealing that while topiramate and lamotrigine show no significant increase in autism spectrum disorder risk post-adjustment, valproate exposure remains a concern due to its association with a higher ASD incidence.
FAP News Today
In the realm of rare diseases, early diagnosis is a critical challenge. Machine learning is emerging as a pivotal tool in identifying familial amyloid polyneuropathy (FAP) patients, promising a new era of precision in genetic testing and timely treatment initiation.
Cardiology March 25th 2024
Medical News Today (MNT)
Innovative research using AI has identified early, gender-specific risk factors for Alzheimer’s, offering new avenues for preventive care in at-risk populations. Understanding these indicators is crucial for healthcare professionals aiming to implement early intervention strategies.
Internal Medicine March 25th 2024
Pharmacy Learning Network
In the midst of stabilizing adolescent drug use rates, the surge in overdose deaths calls for a nuanced understanding and approach to SUDs among young populations.
Family Medicine/General Practice March 19th 2024
This study reveals that prebiotic fiber supplementation can significantly improve cognitive functions in older adults, offering a promising direction for non-pharmacological interventions in age-related cognitive decline.